Status:
COMPLETED
Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Astellas Pharma Canada, Inc.
Conditions:
Renal Transplant Recipients
Eligibility:
All Genders
18-80 years
Brief Summary
Patients undergoing renal transplantation at London Health Sciences Centre, University Hospital and who are participating in the study "A Comparison of Effects of Standard Dose vs Low Dose Advagraf wi...
Eligibility Criteria
Inclusion
- Patients undergoing implantation surgery for renal transplantation at London Health Sciences Centre, University Hospital
- Patients who have consented to the study entitled, "A Comparison of Effects of Standard Dose vs Low Dose Advagraf with IL-2 Receptor Antibody Induction, MMF and Steroids, With or Without ACEi/ARB-based Antihypertensive Therapy on Renal Allograft Histology, Function, and Immune Response"
Exclusion
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01859832
Start Date
May 1 2010
End Date
December 1 2013
Last Update
September 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre, University Hospital
London, Ontario, Canada, N6A 5A5